|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Number of the document | 1951906 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06839824.7 |
| Date of filing the European patent application | 2006-11-10 | |
| (97) | Date of publication of the European application | 2008-08-06 |
| (45) | Date of publication and mention of the grant of the patent | 2010-12-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/060776 |
| Date | 2006-11-10 |
| (87) | Number | WO 2007/059430 |
| Date | 2007-05-24 |
| (30) | Number | Date | Country code |
| 735475 P | 2005-11-10 | US |
| (72) |
FINN, Richard S., US
DERING, Judy, US
SLAMON, Dennis J., US
GINTHER, Charles L., US
CLARK, Edwin A., US
|
| (73) |
The Regents of The University of California,
1111 Franklin Street 5th Floor, Oakland, CA 94607-5200,
US
Bristol-Myers Squibb Pharma Company, P.O. Box 4000, Princeton NJ 08543-4000, US |
| (54) | MOESIN, CAVEOLIN 1 AND YES ASSOCIATED PROTEIN 1 AS PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN BREAST CANCERS |
| MOESIN, CAVEOLIN 1 AND YES ASSOCIATED PROTEIN 1 AS PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN BREAST CANCERS |